StonvexLoading…
StonvexStonvexStonvexCore line items from UAMY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 |
|---|---|---|
Revenue | $39.26M | $14.94M |
Operating Income | $-8.46M | $-2.39M |
Net Income | $-4.34M | $-1.73M |
EPS (Diluted) | $-0.04 | $-0.02 |
Total Assets | $153.93M | $34.64M |
Total Liabilities | $12.97M | $6.04M |
Cash & Equivalents | $30.49M | $18.17M |
Free Cash Flow OCF − CapEx | $-37.50M | $1.79M |
Shares Outstanding | 140.04M | 112.95M |